WO2008012696A3 - Procédés et trousses pour tester l'efficacité de composés thérapeutiques et d'autres thérapies destinés à des cellules et des tissus tumoraux dans une matrice tridimensionnelle - Google Patents
Procédés et trousses pour tester l'efficacité de composés thérapeutiques et d'autres thérapies destinés à des cellules et des tissus tumoraux dans une matrice tridimensionnelle Download PDFInfo
- Publication number
- WO2008012696A3 WO2008012696A3 PCT/IB2007/003494 IB2007003494W WO2008012696A3 WO 2008012696 A3 WO2008012696 A3 WO 2008012696A3 IB 2007003494 W IB2007003494 W IB 2007003494W WO 2008012696 A3 WO2008012696 A3 WO 2008012696A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- therapies
- testing
- cells
- kits
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2691044A CA2691044C (fr) | 2007-06-13 | 2007-06-15 | Procedes et trousses pour tester l'efficacite de composes therapeutiques et d'autres therapies destines a des cellules et des tissus tumoraux dans une matrice tridimensionnelle |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60/813,686 | 2006-06-15 | ||
US92912207P | 2007-06-13 | 2007-06-13 | |
US60/929,122 | 2007-06-13 | ||
US- | 2008-09-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008012696A2 WO2008012696A2 (fr) | 2008-01-31 |
WO2008012696A3 true WO2008012696A3 (fr) | 2011-03-17 |
Family
ID=43607632
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2007/003503 WO2008015581A2 (fr) | 2006-06-15 | 2007-06-15 | Matrices physiologiques tridimensionnelles pour test oncologique et procédés pour leur production et leur utilisation |
PCT/IB2007/003494 WO2008012696A2 (fr) | 2006-06-15 | 2007-06-15 | Procédés et trousses pour tester l'efficacité de composés thérapeutiques et d'autres thérapies destinés à des cellules et des tissus tumoraux dans une matrice tridimensionnelle |
PCT/IB2007/003697 WO2008020337A2 (fr) | 2006-06-15 | 2007-06-15 | Procédés et kits destinés à évaluer et à mesurer le statut oncologique de prélèvements de tissus dans des matrices physiologiques en trois dimensions |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2007/003503 WO2008015581A2 (fr) | 2006-06-15 | 2007-06-15 | Matrices physiologiques tridimensionnelles pour test oncologique et procédés pour leur production et leur utilisation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2007/003697 WO2008020337A2 (fr) | 2006-06-15 | 2007-06-15 | Procédés et kits destinés à évaluer et à mesurer le statut oncologique de prélèvements de tissus dans des matrices physiologiques en trois dimensions |
Country Status (2)
Country | Link |
---|---|
CA (2) | CA2691044C (fr) |
WO (3) | WO2008015581A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009038520B4 (de) * | 2009-08-25 | 2012-07-05 | Universität Rostock | Verfahren und Vorrichtung zur Zellprobendiagnostik |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990002796A1 (fr) * | 1988-09-08 | 1990-03-22 | Marrow-Tech Incorporated | Systeme tridimensionnel de culture cellulaire et tissulaire |
US5712161A (en) * | 1993-12-30 | 1998-01-27 | Nitta Gelatin Inc. | Method for culturing animal cells in collagen drops on a support |
-
2007
- 2007-06-15 WO PCT/IB2007/003503 patent/WO2008015581A2/fr active Application Filing
- 2007-06-15 WO PCT/IB2007/003494 patent/WO2008012696A2/fr active Application Filing
- 2007-06-15 WO PCT/IB2007/003697 patent/WO2008020337A2/fr active Application Filing
- 2007-06-15 CA CA2691044A patent/CA2691044C/fr active Active
- 2007-06-15 CA CA2698338A patent/CA2698338C/fr not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990002796A1 (fr) * | 1988-09-08 | 1990-03-22 | Marrow-Tech Incorporated | Systeme tridimensionnel de culture cellulaire et tissulaire |
US5712161A (en) * | 1993-12-30 | 1998-01-27 | Nitta Gelatin Inc. | Method for culturing animal cells in collagen drops on a support |
Non-Patent Citations (4)
Title |
---|
COSTELLO, P ET AL.: "Screening for tumor therapy sensitivity using an ex vivo invasion assay.", NEURO. ONCOL., vol. 8, October 2006 (2006-10-01), pages 440 * |
COSTELLO, PC ET AL.: "Determination of human brain tumour therapy response using an ex vivo invasion assay provides a potential step toward individualized treatment.", J. CLIN. ONCOL., vol. 24, no. 18S, 20 June 2006 (2006-06-20) * |
KOSHIDA K. ET AL.: "In vitro chemosensitivity test for human genitourinary tumors using collagen gel matrix.", INT. J. UROL., vol. 12, January 2005 (2005-01-01), pages 67 - 72 * |
TAKAMURA Y. ET AL.: "Prediction of chemotherapeutic response by collagen gel droplet embedded culture-drug sensitivity test in human breast cancers.", INT. J. CANCER., vol. 98, 20 March 2002 (2002-03-20), pages 450 - 455 * |
Also Published As
Publication number | Publication date |
---|---|
CA2691044C (fr) | 2016-09-27 |
CA2698338C (fr) | 2015-11-24 |
CA2691044A1 (fr) | 2008-01-31 |
WO2008015581A2 (fr) | 2008-02-07 |
WO2008020337A3 (fr) | 2011-03-17 |
CA2698338A1 (fr) | 2008-02-07 |
WO2008020337A2 (fr) | 2008-02-21 |
WO2008015581A3 (fr) | 2011-02-24 |
WO2008012696A2 (fr) | 2008-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009100105A3 (fr) | Inhibiteurs d'isoformes oncogènes et leurs utilisations | |
WO2008103470A3 (fr) | Composés létaux dépendants du signal de ras oncogénique | |
BRPI0419348B8 (pt) | métodos para produzir o conjugado de maitansinóide-agente de ligação celular | |
WO2008146309A3 (fr) | Variantes génétiques sur les chr 5p12 et 10q26 utilisées comme marqueurs dans l'évaluation, le diagnostic, le pronostic et le traitement d'un risque de cancer du sein | |
WO2009005809A3 (fr) | Compositions et procédés de traitement et de diagnostic d'un cancer | |
WO2006102272A8 (fr) | Methodes permettant de traiter des tumeurs et des tissus cancereux | |
WO2008150496A3 (fr) | Essai de sensibilité à des agents chimiothérapeutiques | |
WO2008036691A3 (fr) | Biomarqueurs du cancer de la prostate et procédés les utilisant | |
WO2007102891A3 (fr) | MATÉRIAUX ET PROCÉDÉS POUR DOSER LA MÉTHYLATION D'ILOTS DE CpG ASSOCIÉS À DES GÈNES DANS L'ÉVALUATION D'UN CANCER | |
WO2010081001A3 (fr) | Fusions de gène récurrent dans le cancer | |
WO2010102251A3 (fr) | Protéines de liaison à il-17 | |
EP2667195A3 (fr) | Biomarqueurs basés sur des taux et méthodes d'utilisation associées | |
NO20080389L (no) | Genetiske varianter i genet TCF7L2 som diagnostiske markorer for risiko for type 2 diabetes mellitus | |
WO2008034866A3 (fr) | Appâts d et utilisations de ceux-ci | |
WO2009100137A3 (fr) | Cellules magnétiques utilisées pour localiser une administration et réparer des tissus | |
WO2007149476A3 (fr) | Déterminations de la mort cellulaire non apoptotique et leurs utilisations | |
WO2007047408A3 (fr) | Application de signature promac | |
EP2527466A3 (fr) | Variants génétiques du CHR2 utilisés comme marqueurs dans l'évaluation, le diagnostic, le pronostic et le traitement d'un risque de cancer du sein | |
WO2007103825A3 (fr) | Polythérapie avec un adénovirus oncolytique | |
EP2598873A4 (fr) | Biomarqueurs du cancer de la prostate et procédés les utilisant | |
WO2008019052A3 (fr) | Procédés et compositions pour l'identification de bio-marqueurs | |
WO2012143481A3 (fr) | Marqueurs du cancer de la prostate | |
WO2009049228A3 (fr) | Compositions et procédés pour estimer des troubles | |
PT1922415E (pt) | Uso de rd9 e is6110 como ácidos nucleicos-alvo para o diagnóstico da tuberculose, e fornecimento de alvos is6110 e rd9 compatíveis com uma utilização multiplex | |
WO2007041502A3 (fr) | Procedes pour la determination de la sensibilite a la therapie cancereuse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2691044 Country of ref document: CA |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07825670 Country of ref document: EP Kind code of ref document: A2 |
|
WPC | Withdrawal of priority claims after completion of the technical preparations for international publication |
Ref document number: 60/813,686 Country of ref document: US Date of ref document: 20091210 Free format text: WITHDRAWN AFTER TECHNICAL PREPARATION FINISHED |